Anne Sullivan
Chief Business Officer @Prilenia
Signup · Get unlimited contacts
WORK HISTORY
Chief Business Officer @Prilenia
Waltham, MA, US
Prilenia Therapeutics B.V. is a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders. The company\'s lead asset, pridopidine, is an oral, highly selective Sigma-1 Receptor agonist that is currently being assessed in clinical studies as a potential treatment option for people living with Huntington\'s disease as well as ALS.
EDUCATION
The Tuck School of Business at Dartmouth
MBA, General Management
College of the Holy Cross
A.B., Economics/Accounting
SKILLS
ABOUT ANNE SULLIVAN
Senior biopharmaceutical executive with over 25 years industry experience working with both private, venture-backed biotech and large, multinational, public biopharmaceuticals. Significant functional expertise in corporate development, operations, marketing and sales with foundational experience in Finance/Accounting.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.